Other
Lactulose
0
Pipeline Programs↗
0
Active Trials↗
1
Companies Involved↗
Lactulose is an early-stage landscape with 0 programs across 1 company. The most active players are Cumberland Pharmaceuticals.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
4
clinical trials
Completed3 · 75%
Unknown status1 · 25%
Clinical Trials
Trial Activity
Comparison Between Lactulose and Lactulose-Paraffin in Cirrhotic Patients
Completed·IInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran·Phase 2·NCT02017119·40 enrolled
Assesment of Lactulose vs Lactobacillus Acidophilus Effect in CKD Patients
Unknown status·—·N/A·NCT05934552·150 enrolled
Efficacy of Polyethylene Glycol vs Lactulose With Isabgol in Acute Fissure-in-Ano: PEGASIS Trial
Completed·—·Phase 2/3·NCT05341180·144 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)